SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0272d5c4f4fe573c
Product Name: SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial
Artg Id: 48406
Artg Name: SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 1994-03-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/6767d693a9fc9390900395b81e890e2f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/36fc7772368648e0d568b87f8b66f8a3.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

0272d5c4f4fe573c

Type

Standard